SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-224328
Filing Date
2021-07-26
Accepted
2021-07-26 16:17:18
Documents
11
Effectiveness Date
2021-07-26

Document Format Files

Seq Description Document Type Size
1 S-3ASR d182414ds3asr.htm S-3ASR 484940
2 EX-1.2 d182414dex12.htm EX-1.2 220035
3 EX-4.2 d182414dex42.htm EX-4.2 281248
4 EX-4.3 d182414dex43.htm EX-4.3 282401
5 EX-5.1 d182414dex51.htm EX-5.1 16552
6 EX-5.2 d182414dex52.htm EX-5.2 8022
7 EX-23.1 d182414dex231.htm EX-23.1 1791
8 GRAPHIC g182414g04a58.jpg GRAPHIC 37523
9 GRAPHIC g182414g64e47.jpg GRAPHIC 77081
10 GRAPHIC g182414g72e22.jpg GRAPHIC 9927
11 GRAPHIC g182414g75d55.jpg GRAPHIC 9885
  Complete submission text file 0001193125-21-224328.txt   1471418
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-258174 | Film No.: 211114350
SIC: 2836 Biological Products, (No Diagnostic Substances)